Last reviewed · How we verify
Tacrolimus 0.1% manufactured by Taro — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Tacrolimus 0.1% manufactured by Taro (Tacrolimus 0.1% manufactured by Taro) — Sun Pharmaceutical Industries, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tacrolimus 0.1% manufactured by Taro TARGET | Tacrolimus 0.1% manufactured by Taro | Sun Pharmaceutical Industries, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tacrolimus 0.1% manufactured by Taro CI watch — RSS
- Tacrolimus 0.1% manufactured by Taro CI watch — Atom
- Tacrolimus 0.1% manufactured by Taro CI watch — JSON
- Tacrolimus 0.1% manufactured by Taro alone — RSS
Cite this brief
Drug Landscape (2026). Tacrolimus 0.1% manufactured by Taro — Competitive Intelligence Brief. https://druglandscape.com/ci/tacrolimus-0-1-manufactured-by-taro. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab